UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rho Kinase Expression in Giant Cell Arteritis: Validating Phosphorylated Ezrin/Radixin/Moesin Intensity Score to Increase Sensitivity of Temporal Artery Biopsy

Journal of rheumatology, 2022-08, Vol.49 (8), p.908-912

2022

Volltextzugriff (PDF)

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Science translational medicine, 2018-01, Vol.10 (423)

2018

Volltextzugriff (PDF)

Current Therapies for ANCA-Associated Vasculitis

Annual review of medicine, 2015-01, Vol.66 (1), p.227-240

2015

Volltextzugriff (PDF)

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Arthritis research & therapy, 2021-01, Vol.23 (1), p.8-8, Article 8

2021

Volltextzugriff (PDF)

Pulmonary Vasculitis

Rheumatic diseases clinics of North America, 2015-05, Vol.41 (2), p.315-331

2015

Volltextzugriff (PDF)

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

Journal of autoimmunity, 2019-12, Vol.105, p.102302-102302, Article 102302

2019

Volltextzugriff (PDF)

Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?

Rheumatic diseases clinics of North America, 2019-08, Vol.45 (3), p.379-398

2019

Volltextzugriff (PDF)

Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Rheumatic diseases clinics of North America, 2015-02, Vol.41 (1), p.1-19

2015

Volltextzugriff (PDF)

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

Arthritis research & therapy, 2015-08, Vol.17 (1), p.213, Article 213

2015

Volltextzugriff (PDF)

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

Arthritis research & therapy, 2023-10, Vol.25 (1), p.1-199, Article 199

2023

Volltextzugriff (PDF)

Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study

Journal of rheumatology, 2019-12, Vol.46 (12), p.1605-1613

2019

Volltextzugriff (PDF)

Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

Nature reviews. Rheumatology, 2024-02, Vol.20 (2), p.77-78

2024

Volltextzugriff (PDF)

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

Analytical chemistry (Washington), 2016-06, Vol.88 (12), p.6317-6325

2016

Volltextzugriff (PDF)

Effectiveness of Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (Wegener's)

Arthritis care & research (2010), 2014-09, Vol.66 (9), p.1403-1409

2014

Volltextzugriff (PDF)

Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment

Journal of rheumatology, 2017-05, Vol.44 (5), p.631-638

2017

Volltextzugriff (PDF)

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

Annals of internal medicine, 2007-11, Vol.147 (9), p.611

2007

Volltextzugriff (PDF)

Biomarkers in ANCA-Associated Vasculitis

Current rheumatology reports, 2013-10, Vol.15 (10), p.363-363, Article 363

2013

Volltextzugriff (PDF)

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study

The Lancet. Rheumatology, 2022-04, Vol.4 (4), p.e243-e246

2022

Volltextzugriff (PDF)

ANCA Are Detectable in Nearly All Patients with Active Severe Wegener’s Granulomatosis

The American journal of medicine, 2007-07, Vol.120 (7), p.643.e9-643.e14

2007

Volltextzugriff (PDF)

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis

Arthritis research & therapy, 2016-01, Vol.18 (27), p.27-27, Article 27

2016

Volltextzugriff (PDF)

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

Current opinion in rheumatology, 2010-11, Vol.22 (6), p.690-695

2010

Volltextzugriff (PDF)

B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab

Journal of rheumatology, 2023-03, Vol.50 (3), p.420

2023

Volltextzugriff (PDF)

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

Current opinion in rheumatology, 2010-11, Vol.22 (6), p.690-695

2010

Volltextzugriff (PDF)

Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis

Journal of autoimmunity, 2015-05, Vol.59, p.43-52

2015

Volltextzugriff (PDF)

Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice

Best practice & research. Clinical rheumatology, 2018-12, Vol.32 (6), p.803-812

2018

Volltextzugriff (PDF)

1 – 25 von 73

Suche als RSS-Feed

Aktive Filter

KollektionFree E-Journal (出版社公開部分のみ）

Zeitschrift / SerieSeminars In Arthritis And Rheumatism

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(65)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(71)
Buchkapitel
(2)

Sprache

Englisch
(73)

Erscheinungsjahr

n.n

Thema

Science & Technology
(51)
Life Sciences & Biomedicine
(50)
Humans
(46)
Rheumatology
(37)
Female
(25)
Male
(24)
Middle Aged
(23)
Adult
(18)
Aged
(15)
Scleroderma
(11)
Systemic Sclerosis
(11)
Biological And Medical Sciences
(9)
Rituximab
(9)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis - Drug Therapy
(8)
Medical Sciences
(8)
Treatment Outcome
(8)
Wegener's Granulomatosis
(8)
Immunosuppressive Agents - Therapeutic Use
(7)
Anca-Associated Vasculitis
(6)
General & Internal Medicine
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rho Kinase Expression in Giant Cell Arteritis: Validating Phosphorylated Ezrin/Radixin/Moesin Intensity Score to Increase Sensitivity of Temporal Artery Biopsy

Plasmacytoid dendritic cells promote systemic sclerosis with a key role for TLR8

Current Therapies for ANCA-Associated Vasculitis

Clinical outcomes of patients with giant cell arteritis treated with tocilizumab in real-world clinical practice: decreased incidence of new visual manifestations

Pulmonary Vasculitis

The association of serum interleukin-6 levels with clinical outcomes in antineutrophil cytoplasmic antibody-associated vasculitis

Treatment of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Is There Still a Role for Cyclophosphamide?

Current Landscape of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis

Nilotinib (Tasigna™) in the treatment of early diffuse systemic sclerosis: an open-label, pilot clinical trial

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis

Physical or Occupational Therapy Use in Systemic Sclerosis: A Scleroderma Patient-centered Intervention Network Cohort Study

Advances in the treatment of polymyalgia rheumatica and giant cell arteritis

Using Mass Spectrometry to Quantify Rituximab and Perform Individualized Immunoglobulin Phenotyping in ANCA-Associated Vasculitis

Effectiveness of Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis (Wegener's)

Proteomic Analysis of Sera from Individuals with Diffuse Cutaneous Systemic Sclerosis Reveals a Multianalyte Signature Associated with Clinical Improvement during Imatinib Mesylate Treatment

Antiproteinase 3 antineutrophil cytoplasmic antibodies and disease activity in Wegener granulomatosis

Biomarkers in ANCA-Associated Vasculitis

Systemic sclerosis and COVID-19 vaccines: a SPIN Cohort study

ANCA Are Detectable in Nearly All Patients with Active Severe Wegener’s Granulomatosis

Stress granules and RNA processing bodies are novel autoantibody targets in systemic sclerosis

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

B Cell Reconstitution is Associated With COVID-19 Booster Vaccine Responsiveness in Patients Previously Seronegative Treated With Rituximab

Targeting tyrosine kinases: a novel therapeutic strategy for systemic sclerosis

Allosteric modulation of proteinase 3 activity by anti-neutrophil cytoplasmic antibodies in granulomatosis with polyangiitis

Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice

Aktive Filter

Suchergebnisse filtern